Eastern Hepatobiliary Surgery Hospital

This study tests a new cell therapy called super Hi-TCR-T cells in 30 people with advanced liver cancer that has not responded to other treatments. The cells are designed to attack multiple targets on cancer cells. The goal is to see if the treatment is safe and can slow or stop …

This study is for people with advanced bile duct cancer (ICC) that cannot be removed by surgery. It tests a treatment that delivers chemotherapy directly to the liver (HAIC) along with drugs that boost the immune system. The goal is to see if this combination can shrink tumors an…

This study compares two ways of giving the drugs bevacizumab and atezolizumab for advanced liver cancer that occurs with fatty liver disease. One group gets the drugs one after the other (sequential), the other gets them together (concurrent). The goal is to see which approach wo…